Seline E. Miller - 11 Feb 2022 Form 4 Insider Report for CATALYST BIOSCIENCES, INC. (GYRE)

Role
SVP Finance; Interim CFO & PAO
Signature
/s/ Seline Miller
Issuer symbol
GYRE
Transactions as of
11 Feb 2022
Net transactions value
$0
Form type
4
Filing time
23 Feb 2022, 15:08:08 UTC
Previous filing
16 Feb 2022
Next filing
10 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBIO Stock Option (Right to Buy) Award $0 +107,500 $0.000000 107,500 11 Feb 2022 Common Stock 107,500 $0.5200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option will vest on the one-year anniversary of the vesting commencement date of February 11, 2022, and 1/48 of the shares subject to the option will vest on each monthly anniversary of the vesting commencement date thereafter.